62 results
Page 3 of 4
10-K
ei9u3bkc
18 Mar 21
Annual report
4:25pm
8-K
EX-99.1
melb01h
18 Mar 21
Results of Operations and Financial Condition
4:11pm
8-K
EX-99.1
w9gn4tr
15 Mar 21
ALX Oncology Announces Appointment of Sophia Randolph, M.D., Ph.D., to Board of Directors
8:30am
424B4
cpa25
11 Dec 20
Prospectus supplement with pricing info
12:00am
DRS
2d6ji
24 Nov 20
Draft registration statement
12:00am
8-K
EX-99.1
upyl7m
12 Nov 20
ALX Oncology Reports Third Quarter 2020 Financial Results and Provides Clinical Development and Operational Highlights
4:20pm
10-Q
oni paw881
27 Aug 20
Quarterly report
4:49pm
8-K
EX-99.1
fpawm
27 Aug 20
ALX Oncology Reports Second Quarter 2020 Financial Results and Provides Operational and Clinical Highlights
4:16pm
424B4
q79 umb1dcj
17 Jul 20
Prospectus supplement with pricing info
4:27pm
S-1
wwhv3kkf5o4
26 Jun 20
IPO registration
4:34pm
S-1
EX-10.15
4y56jwsqrv
26 Jun 20
IPO registration
4:34pm
S-1
EX-10.14
fdxkn7 x61o
26 Jun 20
IPO registration
4:34pm
S-1
EX-10.13
ayp2ftr29figb28
26 Jun 20
IPO registration
4:34pm
DRSLTR
fcgyllb5vpalcct9znw
12 Jun 20
Correspondence regarding draft registration statement
12:00am
DRS/A
EX-10.13
1im4c635pha me
12 Jun 20
Draft registration statement (amended)
12:00am
DRS/A
pt7evwgo
12 Jun 20
Draft registration statement (amended)
12:00am